Cover
Cover | Mar. 08, 2024 |
Cover [Abstract] | |
Entity Registrant Name | THC Therapeutics, Inc. |
Entity Central Index Key | 0001404935 |
Document Type | 8-K/A |
Amendment Flag | true |
Entity Emerging Growth Company | false |
Document Period End Date | Mar. 08, 2024 |
Entity File Number | 000-555994 |
Entity Incorporation State Country Code | NV |
Entity Tax Identification Number | 26-0164981 |
Entity Address Address Line 1 | 11700 W. Charleston Blvd., #73 |
Entity Address City Or Town | Las Vegas |
Entity Address State Or Province | NV |
Entity Address Postal Zip Code | 89135 |
City Area Code | 833 |
Local Phone Number | 420-8428 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Amendment Description | Explanatory Note: This Current Report on Form 8-K/A is being filed to amend the Current Report of Form 8-K filed with the Securities and Exchange Commission on March 14, 2024 (the “Original 8-K”). Prior to the filing of the Original 8-K we had not received a letter from Gries & Associates, LLC as described below. Subsequent to that filing, we received such letter and are filing this amendment to include the letter as Exhibit 16.1. |